Pre-release: this release has not been published. Identifiers are permanent; descriptions may still change.

HB 5045 (2019-2020)

https://ontology.bommaritollc.com/id/01a0d567-1ada-7755-ad1f-7e6e1e5bc789

adms:identifier	mi-legislature-measure 2019-2020/HB/5045
dcterms:temporal	Michigan Legislature, 2019-2020 session
primary sponsor	Henry Vaupel
prov:wasDerivedFrom	evidence from https://www.legislature.mi.gov/Bills/Bill?ObjectName=2019-HB-5045 evidence from https://www.legislature.mi.gov/Bills/Bill?ObjectName=2019-HB-5045 evidence from https://www.legislature.mi.gov/Bills/Bill?ObjectName=2019-HB-5045
schema:legislationChanges	MCL 333.7303a
schema:legislationIdentifier	HB 5045
schema:legislationJurisdiction	Michigan
schema:legislationType	bill
schema:name	Health: pharmaceuticals; requirement to obtain and review a report from the Michigan automated prescription system (MAPS); exempt certain controlled substances for the treatment of epilepsy or seizure disorders. Amends sec. 7303a of 1978 PA 368 (MCL 333.7303a ).en
schema:sponsor	Mary Whiteford LaTanya Garrett Henry Vaupel
schema:url	https://www.legislature.mi.gov/Bills/Bill?ObjectName=2019-HB-5045
skos:prefLabel	HB 5045 (2019-2020)en
status	in committee
status date	2019-10-08xsd:date